#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IgA nephropathy Polyneuropathy Hyperphagia Homocystinuria Follicular lymphoma stage II MELAS syndrome Dupuytren's contracture Interstitial lung disease Amyotrophic lateral sclerosis Cytomegalovirus infection Cardiomyopathy Rhabdomyosarcoma Endometrial cancer recurrent Epstein-Barr virus infection Diffuse large B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus Splenic marginal zone lymphoma – Life with Disease Uterine leiomyosarcoma – Trials in Disease Haemophilia B with anti factor IX – Treatment Mucopolysaccharidosis – Life with Disease Rosai-Dorfman syndrome Primary hyperoxaluria Behcet’s syndrome – Diagnostics Fragile X syndrome – Basic Information Splenic marginal zone lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phleum Pratense Pollen Extract Heparin Calcium Ustekinumab Ly4100511 Ngi226 Tin816 Nms-03305293 Abiraterone Clobetasol Tralokinumab Sufentanil Citrate AP31969 SULFATE Ivonescimab Telitacicept Crizanlizumab Benzylpenicillin Petrelintide RO7288817 Depemokimab Pelacarsen More therapies…

    Learn about Your Condition

    Lichen planopilaris Hand dermatitis Gastrointestinal disorder Intracranial calcification Femoral neck fracture Transplantation complication Primary adrenal insufficiency Gastrointestinal carcinoma Sjogren's syndrome Marfan's syndrome Colorectal cancer stage III Eye pain Muscle spasticity Pustular psoriasis Plasmablastic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not recruiting

    3 1
    Investigated Drugs:
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain

  • Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lanreotide
    • Octreotide
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Croatia Czechia Estonia Finland +14

  • Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Calcium Folinate
    • Capecitabine
    Belgium France Germany Ireland Italy Poland +1

  • Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Aminocaproic Acid
    • Blood And Related Products
    • Etamsylate
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Giredestrant
    • Abemaciclib
    • Fulvestrant
    Austria Belgium Finland France Germany Greece +7

  • Study of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Giredestrant
    • Anastrozole
    • Anhydrous Docetaxel
    Belgium France Germany Hungary Italy Poland +2

  • Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
    • Sunitinib
    Czechia Denmark France Germany Hungary Italy +5

  • Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Renal cell carcinoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Lbl-007
    • Surzebiclimab
    • Tislelizumab
    France Italy Poland Spain
Previous Page
1 … 60 61 62 63 64 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!